metaMe Health Valuation Estimate
metaMe Health Valuation as of Last Funding Round
metaMe Health Company Overview
metaMe Health is changing the way to deal with disorders and pain. Not with more medicine but through prescription digital therapeutics (PDTs): software applications that unlock the power of the mind. They are prescribed digital therapeutics that train the brain to help manage various chronic conditions. And it happens on a smartphone or tablet, so patients can unlock the power to heal anywhere they want. In 2022, they raised $2.2 million to bring their IBS solution to the market. The funding round was led by Hyde Park Angels, with additional investments from other individuals.
metaMe Health Valuation History
metaMe Health Stock Price
The stock price of metaMe Health can be calculated by taking the valuation of the company divided by the number of shares outstanding. Because a private company can issue new shares at any time, we do not know the current number of shares outstanding.
For illustrative purposes, however, assuming metaMe Health has issued 250 million shares, at the estimated UpMarket valuation of $10.58 million, each share of metaMe Health stock would be worth $0.04.
Buy metaMe Health Stock
If you would like to buy shares in metaMe Health, please provide your information in the form at the top of this page and click the button titled “I want to buy this stock.”
One of our investor relations team members will contact you to discuss metaMe Health stock availability. Note: inquiries are non-binding and shares may only be purchased by accredited investors that meet all eligibility criteria.
UpMarket has offered many similar companies as Pre-IPO investments, including Airbnb, SpaceX, ByteDance, Plaid, Kraken, Databricks, and others. UpMarket also often has funds available that invest in a portfolio of companies potentially including, metaMe Health as well.
metaMe Health Management
Name | Position |
---|---|
Tim Rudolphi | CEO |
Adam Y. | CTO |